Lung oncology Clinical Trials in New York, NY

As of June 2026, 130 paid clinical trials are recruiting for Lung oncology in New York, New York. Lung oncology trials investigate EGFR, ALK, KRAS, and other driver-mutation targeted therapies alongside immunotherapy combinations for non-small cell, small cell, and mesothelioma studies. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

130 clinical trials for Lung oncology

·Clear filters·↓ Download CSV

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

for Carcinoma, Non-Small-Cell Lung

18 locations incl. Gilbert

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT04165798·Recruiting

Apply to this trial

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

for Small Cell Lung Cancer

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT04199741·Phase 1, Phase 2·Recruiting

Apply to this trial

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

for Lung Cancer

1 location in New York

Sponsor: CivaTech Oncology

Sex: All·Age: 18+

Code: NCT03290534·Phase 2·Recruiting

Apply to this trial

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

for Triple Negative Breast Cancer

12 locations incl. San Carlos

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT03808337·Phase 2·Recruiting

Apply to this trial

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for Head and Neck Carcinoma

14 locations incl. Santa Rosa

Sponsor: VM Oncology, LLC

Sex: All·Age: 18 - 80

Code: NCT03556228·Phase 1, Phase 2·Recruiting

Apply to this trial

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for Cancer, Metastatic

67 locations incl. Birmingham

Sponsor: Massive Bio, Inc.

Sex: All·Age: All ages

Code: NCT03452774·Recruiting

Apply to this trial

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

for Non-Small Cell Lung Cancer

40 locations incl. La Jolla

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18+

Code: NCT02468024·Phase 3·Recruiting

Apply to this trial

WTC Chest CT Imaging Archive

for Chronic Airway Disease

1 location in New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT03295279·Enrolling By Invitation

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

for Non-Small Cell Lung Cancer

Drug: Cabozantinib

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT01639508·Phase 2·Recruiting

Apply to this trial

Lung Cancer Biomarkers and Screening

for Lung Cancer

1 location in New York

Sponsor: NYU Langone Health

Sex: All·Age: 50+·Accepts healthy volunteers

Code: NCT00301119·Recruiting

Apply to this trial

Conditions in Lung oncology (New York, NY)

Non-small cell lung cancer (NSCLC)· 107 Lung cancer· 28 Mesothelioma· 9 Small cell lung cancer· 6